Genetic predictors to acupuncture response for hot flashes: an exploratory study of breast cancer survivors.

Can Your Genes Predict Whether Acupuncture Will Help With Hot Flashes?

If you're a breast cancer survivor dealing with hot flashes, you know how disruptive they can be. Many women in this situation can't take hormone therapy, making the search for effective alternatives especially important. Acupuncture has emerged as a promising option — but why does it work wonderfully for some women and not others? A new study suggests the answer may be written in your DNA.

Researchers looked at data from 108 breast cancer survivors who had participated in a clinical trial testing acupuncture versus a medication called gabapentin for hot flash relief. The team examined specific variations in four genes — ADORA1, COMT, TCL1A, and TRPV1 — all of which play roles in how the body regulates temperature, transmits nerve signals, and manages inflammation. These are the same biological pathways that acupuncture is believed to influence.

The results were striking. Among women who received acupuncture, those who carried at least one of six specific genetic variants were far more likely to experience meaningful relief — defined as a 50% or greater reduction in hot flash severity. About 70% of these genetic "carriers" responded well to acupuncture, compared to only 37.5% of women without those variants. Importantly, these same genetic differences did NOT predict who would respond to gabapentin, suggesting the effect is specific to acupuncture rather than a general placebo response.

This research is still early-stage and exploratory, but it points toward an exciting future where a simple genetic test might help determine whether acupuncture is likely to be a good fit for managing your hot flashes before you even begin treatment.

If you're interested in exploring acupuncture for hot flash relief, speak with a licensed acupuncturist who has experience working with breast cancer survivors.

This exploratory study investigated whether single nucleotide polymorphisms (SNPs) in genes governing neurotransmission, thermoregulation, and inflammation could predict acupuncture response for hot flashes in breast cancer survivors. Drawing from a completed RCT (NCT01005108), researchers analyzed DNA from 108 participants, assaying SNPs in ADORA1, COMT, TCL1A, and TRPV1. Primary outcome was defined as ≥50% reduction in hot flash composite score post-treatment.

Among 57 women receiving acupuncture (electroacupuncture or sham), carriers of at least one of six identified genotypes demonstrated significantly higher response rates versus non-carriers (70.3% vs. 37.5%, P=0.035). Critically, these same six genotypes showed no predictive value in the 51 women receiving pharmacological treatment — gabapentin or placebo (37.5% vs. 37.5%, P=1.0) — suggesting acupuncture-specific mechanistic pathways.

Clinical takeaway: Genetic profiling of ADORA1, COMT, TCL1A, and TRPV1 variants may eventually support personalized acupuncture treatment protocols for hot flash management in oncology populations, pending larger confirmatory trials.